Ally Bridge Group (NY) LLC 4
4 · ProMIS Neurosciences Inc. · Filed Oct 24, 2025
Insider Transaction Report
Form 4
ABG Management Ltd.
10% Owner
Transactions
- Award
Option (right to buy)
2025-10-22+40,000→ 40,000 totalExercise: $0.45Exp: 2035-10-22→ Common Shares (40,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to this option vested on the date of grant and the remaining shares shall vest in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- [F2]This option was granted to Slanix Alex, a director of the Issuer and an employee of Ally Bridge Group (NY) LLC, which manages the investments of Ally Bridge MedAlpha Master Fund L.P. Dr. Alex holds any equity-based compensation awarded to him for his service as a director of the Issuer for the benefit of Ally Bridge MedAlpha Master Fund L.P. Any proceeds from the sale of shares upon exercise of this award shall be remitted to Ally Bridge MedAlpha Master Fund L.P. The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such securities are beneficially owned by him for Section 16 or any other purpose.